Industry Research Reports

Home > Reports > Service & Software > Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-12

Pages: 97 Pages

Report ld: 4650647

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Canine Tumor Screening Market Size(US$)

CAGR 2025-2031

6.5%

Market Size,2031

USD 635

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 435 million

Market Forecast in 2031(Value)

US$ 635 million

CAGR

6.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Canine Tumor Screening was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

Canine liquid biopsy is a method of analyzing biomarkers in body fluids (such as blood, urine or saliva) to detect the presence of cancer or monitor the progression of cancer. Unlike traditional tissue biopsies, liquid biopsies are non-invasive, fast and convenient. By obtaining a small blood sample, doctors can analyze free DNA, circulating tumor cells, exosomes, etc. to obtain information about the tumor.

North American market for Canine Tumor Screening was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Canine Tumor Screening was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Canine Tumor Screening was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Canine Tumor Screening include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Canine Tumor Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Canine Tumor Screening by region & country, by Type, and by Application.

The Canine Tumor Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Tumor Screening.

MARKET SEGMENTATION

By Company

PetDx
CYTOGEN
BioChain
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cut Biopsy
Needle Biopsy

Segment by Application

Pet Hospital
Clinic

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Canine Tumor Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Canine Tumor Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Canine Tumor Screening in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Canine Tumor Screening Product Introduction

1.2 Global Canine Tumor Screening Market Size Forecast (2020-2031)

1.3 Canine Tumor Screening Market Trends & Drivers

1.3.1 Canine Tumor Screening Industry Trends

1.3.2 Canine Tumor Screening Market Drivers & Opportunity

1.3.3 Canine Tumor Screening Market Challenges

1.3.4 Canine Tumor Screening Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Canine Tumor Screening Players Revenue Ranking (2024)

2.2 Global Canine Tumor Screening Revenue by Company (2020-2025)

2.3 Key Companies Canine Tumor Screening Manufacturing Base Distribution and Headquarters

2.4 Key Companies Canine Tumor Screening Product Offered

2.5 Key Companies Time to Begin Mass Production of Canine Tumor Screening

2.6 Canine Tumor Screening Market Competitive Analysis

2.6.1 Canine Tumor Screening Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Canine Tumor Screening Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Tumor Screening as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cut Biopsy

3.1.2 Needle Biopsy

3.2 Global Canine Tumor Screening Sales Value by Type

3.2.1 Global Canine Tumor Screening Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Canine Tumor Screening Sales Value, by Type (2020-2031)

3.2.3 Global Canine Tumor Screening Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pet Hospital

4.1.2 Clinic

4.2 Global Canine Tumor Screening Sales Value by Application

4.2.1 Global Canine Tumor Screening Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Canine Tumor Screening Sales Value, by Application (2020-2031)

4.2.3 Global Canine Tumor Screening Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Canine Tumor Screening Sales Value by Region

5.1.1 Global Canine Tumor Screening Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Canine Tumor Screening Sales Value by Region (2020-2025)

5.1.3 Global Canine Tumor Screening Sales Value by Region (2026-2031)

5.1.4 Global Canine Tumor Screening Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Canine Tumor Screening Sales Value, 2020-2031

5.2.2 North America Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Canine Tumor Screening Sales Value, 2020-2031

5.3.2 Europe Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Canine Tumor Screening Sales Value, 2020-2031

5.4.2 Asia Pacific Canine Tumor Screening Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Canine Tumor Screening Sales Value, 2020-2031

5.5.2 South America Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Canine Tumor Screening Sales Value, 2020-2031

5.6.2 Middle East & Africa Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Canine Tumor Screening Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Canine Tumor Screening Sales Value, 2020-2031

6.3 United States

6.3.1 United States Canine Tumor Screening Sales Value, 2020-2031

6.3.2 United States Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Canine Tumor Screening Sales Value, 2020-2031

6.4.2 Europe Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Canine Tumor Screening Sales Value, 2020-2031

6.5.2 China Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.5.3 China Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Canine Tumor Screening Sales Value, 2020-2031

6.6.2 Japan Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Canine Tumor Screening Sales Value, 2020-2031

6.7.2 South Korea Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Canine Tumor Screening Sales Value, 2020-2031

6.8.2 Southeast Asia Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Canine Tumor Screening Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Canine Tumor Screening Sales Value, 2020-2031

6.9.2 India Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

6.9.3 India Canine Tumor Screening Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 PetDx

7.1.1 PetDx Profile

7.1.2 PetDx Main Business

7.1.3 PetDx Canine Tumor Screening Products, Services and Solutions

7.1.4 PetDx Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.1.5 PetDx Recent Developments

7.2 CYTOGEN

7.2.1 CYTOGEN Profile

7.2.2 CYTOGEN Main Business

7.2.3 CYTOGEN Canine Tumor Screening Products, Services and Solutions

7.2.4 CYTOGEN Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.2.5 CYTOGEN Recent Developments

7.3 BioChain

7.3.1 BioChain Profile

7.3.2 BioChain Main Business

7.3.3 BioChain Canine Tumor Screening Products, Services and Solutions

7.3.4 BioChain Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.3.5 BioChain Recent Developments

7.4 Small Door

7.4.1 Small Door Profile

7.4.2 Small Door Main Business

7.4.3 Small Door Canine Tumor Screening Products, Services and Solutions

7.4.4 Small Door Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.4.5 Small Door Recent Developments

7.5 ANGLE

7.5.1 ANGLE Profile

7.5.2 ANGLE Main Business

7.5.3 ANGLE Canine Tumor Screening Products, Services and Solutions

7.5.4 ANGLE Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.5.5 ANGLE Recent Developments

7.6 BioChain Institute Inc.

7.6.1 BioChain Institute Inc. Profile

7.6.2 BioChain Institute Inc. Main Business

7.6.3 BioChain Institute Inc. Canine Tumor Screening Products, Services and Solutions

7.6.4 BioChain Institute Inc. Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.6.5 BioChain Institute Inc. Recent Developments

7.7 CANCAN DIAGNOSTICS.

7.7.1 CANCAN DIAGNOSTICS. Profile

7.7.2 CANCAN DIAGNOSTICS. Main Business

7.7.3 CANCAN DIAGNOSTICS. Canine Tumor Screening Products, Services and Solutions

7.7.4 CANCAN DIAGNOSTICS. Canine Tumor Screening Revenue (US$ Million) & (2020-2025)

7.7.5 CANCAN DIAGNOSTICS. Recent Developments

8 Industry Chain Analysis

8.1 Canine Tumor Screening Industrial Chain

8.2 Canine Tumor Screening Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Canine Tumor Screening Sales Model

8.5.2 Sales Channel

8.5.3 Canine Tumor Screening Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Canine Tumor Screening Market Trends

Table 2. Canine Tumor Screening Market Drivers & Opportunity

Table 3. Canine Tumor Screening Market Challenges

Table 4. Canine Tumor Screening Market Restraints

Table 5. Global Canine Tumor Screening Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Canine Tumor Screening Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Canine Tumor Screening Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Canine Tumor Screening Product Type

Table 9. Key Companies Time to Begin Mass Production of Canine Tumor Screening

Table 10. Global Canine Tumor Screening Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Tumor Screening as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Canine Tumor Screening Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Canine Tumor Screening Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Canine Tumor Screening Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Canine Tumor Screening Sales Market Share in Value by Type (2020-2025)

Table 17. Global Canine Tumor Screening Sales Market Share in Value by Type (2026-2031)

Table 18. Global Canine Tumor Screening Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Canine Tumor Screening Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Canine Tumor Screening Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Canine Tumor Screening Sales Market Share in Value by Application (2020-2025)

Table 22. Global Canine Tumor Screening Sales Market Share in Value by Application (2026-2031)

Table 23. Global Canine Tumor Screening Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Canine Tumor Screening Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Canine Tumor Screening Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Canine Tumor Screening Sales Value by Region (2020-2025) & (%)

Table 27. Global Canine Tumor Screening Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Canine Tumor Screening Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Canine Tumor Screening Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Canine Tumor Screening Sales Value, (2026-2031) & (US$ Million)

Table 31. PetDx Basic Information List

Table 32. PetDx Description and Business Overview

Table 33. PetDx Canine Tumor Screening Products, Services and Solutions

Table 34. Revenue (US$ Million) in Canine Tumor Screening Business of PetDx (2020-2025)

Table 35. PetDx Recent Developments

Table 36. CYTOGEN Basic Information List

Table 37. CYTOGEN Description and Business Overview

Table 38. CYTOGEN Canine Tumor Screening Products, Services and Solutions

Table 39. Revenue (US$ Million) in Canine Tumor Screening Business of CYTOGEN (2020-2025)

Table 40. CYTOGEN Recent Developments

Table 41. BioChain Basic Information List

Table 42. BioChain Description and Business Overview

Table 43. BioChain Canine Tumor Screening Products, Services and Solutions

Table 44. Revenue (US$ Million) in Canine Tumor Screening Business of BioChain (2020-2025)

Table 45. BioChain Recent Developments

Table 46. Small Door Basic Information List

Table 47. Small Door Description and Business Overview

Table 48. Small Door Canine Tumor Screening Products, Services and Solutions

Table 49. Revenue (US$ Million) in Canine Tumor Screening Business of Small Door (2020-2025)

Table 50. Small Door Recent Developments

Table 51. ANGLE Basic Information List

Table 52. ANGLE Description and Business Overview

Table 53. ANGLE Canine Tumor Screening Products, Services and Solutions

Table 54. Revenue (US$ Million) in Canine Tumor Screening Business of ANGLE (2020-2025)

Table 55. ANGLE Recent Developments

Table 56. BioChain Institute Inc. Basic Information List

Table 57. BioChain Institute Inc. Description and Business Overview

Table 58. BioChain Institute Inc. Canine Tumor Screening Products, Services and Solutions

Table 59. Revenue (US$ Million) in Canine Tumor Screening Business of BioChain Institute Inc. (2020-2025)

Table 60. BioChain Institute Inc. Recent Developments

Table 61. CANCAN DIAGNOSTICS. Basic Information List

Table 62. CANCAN DIAGNOSTICS. Description and Business Overview

Table 63. CANCAN DIAGNOSTICS. Canine Tumor Screening Products, Services and Solutions

Table 64. Revenue (US$ Million) in Canine Tumor Screening Business of CANCAN DIAGNOSTICS. (2020-2025)

Table 65. CANCAN DIAGNOSTICS. Recent Developments

Table 66. Key Raw Materials Lists

Table 67. Raw Materials Key Suppliers Lists

Table 68. Canine Tumor Screening Downstream Customers

Table 69. Canine Tumor Screening Distributors List

Table 70. Research Programs/Design for This Report

Table 71. Key Data Information from Secondary Sources

Table 72. Key Data Information from Primary Sources

List of Figures

Figure 1. Canine Tumor Screening Product Picture

Figure 2. Global Canine Tumor Screening Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Canine Tumor Screening Sales Value (2020-2031) & (US$ Million)

Figure 4. Canine Tumor Screening Report Years Considered

Figure 5. Global Canine Tumor Screening Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Canine Tumor Screening Revenue in 2024

Figure 7. Canine Tumor Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Cut Biopsy Picture

Figure 9. Needle Biopsy Picture

Figure 10. Global Canine Tumor Screening Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Canine Tumor Screening Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Pet Hospital

Figure 13. Product Picture of Clinic

Figure 14. Global Canine Tumor Screening Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Canine Tumor Screening Sales Value Market Share by Application, 2024 & 2031

Figure 16. North America Canine Tumor Screening Sales Value (2020-2031) & (US$ Million)

Figure 17. North America Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

Figure 18. Europe Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 19. Europe Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

Figure 20. Asia Pacific Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 21. Asia Pacific Canine Tumor Screening Sales Value by Region (%), 2024 VS 2031

Figure 22. South America Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 23. South America Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

Figure 24. Middle East & Africa Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 25. Middle East & Africa Canine Tumor Screening Sales Value by Country (%), 2024 VS 2031

Figure 26. Key Countries/Regions Canine Tumor Screening Sales Value (%), (2020-2031)

Figure 27. United States Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 28. United States Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 29. United States Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 30. Europe Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 32. Europe Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 33. China Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 34. China Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 35. China Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 36. Japan Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 37. Japan Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 38. Japan Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 39. South Korea Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 40. South Korea Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 41. South Korea Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 42. Southeast Asia Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 44. Southeast Asia Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 45. India Canine Tumor Screening Sales Value, (2020-2031) & (US$ Million)

Figure 46. India Canine Tumor Screening Sales Value by Type (%), 2024 VS 2031

Figure 47. India Canine Tumor Screening Sales Value by Application (%), 2024 VS 2031

Figure 48. Canine Tumor Screening Industrial Chain

Figure 49. Canine Tumor Screening Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What is the annual compound growth rate of the global Canine Tumor Screening market size from 2025 to 2031? shouQi

What was the global market size of Canine Tumor Screening in 2025? shouQi

Which companies rank high in the global Canine Tumor Screening market? shouQi

What was the global market size of Canine Tumor Screening in 2031? shouQi

Related Reports

Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Canine Tumor Screening market is projected to grow from US$ 435 million in 2025 to US$ 672 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 120
USD 4900.00
(Single User License)
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Canine Tumor Screening market size was US$ 435 million in 2025 and is forecast to reach a readjusted size of US$ 672 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 80
USD 4250.00
(Single User License)
Global Canine Tumor Screening Market Research Report 2026
The global Canine Tumor Screening market was valued at US$ 435 million in 2025 and is anticipated to reach US$ 672 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 104
USD 2900.00
(Single User License)
Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Canine Tumor Screening was estimated to be worth US$ 435 million in 2025 and is projected to reach US$ 672 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 3950.00
(Single User License)
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Canine Tumor Screening market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 80
USD 4250.00
(Single User License)
Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Canine Tumor Screening market is projected to grow from US$ 411 million in 2024 to US$ 635 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 127
USD 4900.00
(Single User License)
Global Canine Tumor Screening Market Research Report 2025
The global market for Canine Tumor Screening was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 635 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-12
Pages: 72
USD 2900.00
(Single User License)
Global and Japan Canine Tumor Screening Market Report & Forecast 2024-2030
The global Canine Tumor Screening revenue was US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 93
USD 4350.00
(Single User License)
Canine Tumor Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Canine Tumor Screening was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 96
USD 3950.00
(Single User License)
Global Canine Tumor Screening Market Insights, Forecast to 2030
Valued at US$ 411 million in 2024, the global Canine Tumor Screening market is forecast to reach US$ 600 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2024-12-12
Pages: 128
USD 4900.00
(Single User License)

Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Canine Tumor Screening market is projected to grow from US$ 435 million in 2025 to US$ 672 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 120
USD 4900.00 (Single User License)
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Canine Tumor Screening market size was US$ 435 million in 2025 and is forecast to reach a readjusted size of US$ 672 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 80
USD 4250.00 (Single User License)
Global Canine Tumor Screening Market Research Report 2026
The global Canine Tumor Screening market was valued at US$ 435 million in 2025 and is anticipated to reach US$ 672 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 104
USD 2900.00 (Single User License)
Canine Tumor Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Canine Tumor Screening was estimated to be worth US$ 435 million in 2025 and is projected to reach US$ 672 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 97
USD 3950.00 (Single User License)
Global Canine Tumor Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Canine Tumor Screening market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 635 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 80
USD 4250.00 (Single User License)
Global Canine Tumor Screening Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Canine Tumor Screening market is projected to grow from US$ 411 million in 2024 to US$ 635 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 127
USD 4900.00 (Single User License)
Global Canine Tumor Screening Market Research Report 2025
The global market for Canine Tumor Screening was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 635 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-12
Pages: 72
USD 2900.00 (Single User License)
Global and Japan Canine Tumor Screening Market Report & Forecast 2024-2030
The global Canine Tumor Screening revenue was US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2024-12-12
Pages: 93
USD 4350.00 (Single User License)
Canine Tumor Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Canine Tumor Screening was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 600 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 96
USD 3950.00 (Single User License)
Global Canine Tumor Screening Market Insights, Forecast to 2030
Valued at US$ 411 million in 2024, the global Canine Tumor Screening market is forecast to reach US$ 600 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2024-12-12
Pages: 128
USD 4900.00 (Single User License)